[ad_1]
The machine, which is set to be installed at AIIMS-Delhi for evaluation and clinial trials by October 2025, is expected to cut MRI costs for patients by around 50 per cent, it added.
Besides the cost cut for use of the medical tool, the indigenous machine also aims to reduce India’s dependence on foreign imports and increase access to the public.
‘Major Step Towards Aatmanirbhar Bharat, Reduce Imports…’
Accoridng to AIIMS-Delhi Director Dr M Srinivas, at present majority of healthcare equipment in India, such as critical and post operative care, ICUs, MRIs machines and robotics, are imported.
“The development of this indigenous MRI machine is a major step towards becoming Atmanirbhar Bharat to reduce dependence on foreign imported devices. As we have the experience of using the best of global equipment, we can compare and provide feedback for necessary improvements so that the machine is clinically proven for deployment in health facilities. The aim is also to ensure that it meets standards,” Srinivas said.
According to Professor Rama Jayasundar, head of department of Nuclear Magnetic Resonance at AIIMS-Delhi, “The initiative will considerably reduce the cost of MRI scanning and reliance on imported machines.”
About MeitY’s SAMEER Initiative
SAMEER has spearheaded the development of two critical healthcare technologies — the 1.5 Tesla MRI scanner, and a 6 MEV Linear Accelerator.
The MRI scanner is a non-invasive medical imaging test used to visualise soft tissues; while the Linear Accelerator is utilised for cancer treatment using high-energy X-rays or electrons.
Both projects have received financial support from MeitY to help India move towards import substitution.
(With inputs from Agencies)
[ad_2]
Source link
